MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock
$83K
Net cash provided by
(used in) financing...
$83K
Cash, cash
equivalents, restricted...
-$3,563K
Canceled cashflow
$83K
Share-based payment
arrangement, noncash expense
$345K
Increase (decrease) in
accounts payable, trade
$125K
Non-cash financial
expenses
-$4K
Depreciation
$2K
Net cash provided by
(used in) operating...
-$3,646K
Canceled cashflow
$476K
Net loss
-$2,733K
Increase in prepaid
expenses
$959K
Increase (decrease) in
employee related...
-$319K
Decrease (increase) in
other current assets
$47K
Increase (decrease) in
other accounts...
-$19K
Increase (decrease) in
operating lease liability
-$4K
Back
Back
Cash Flow
Silexion Therapeutics Corp (SLXNW)
Silexion Therapeutics Corp (SLXNW)
source: myfinsight.com